Gail Cawkwell
CIK 1761167 · Chief Medical Officer · last filed 2023-07-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$41.4K
Companies
2
Total Filings
26
Lifetime Open-Market Net
-$39.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Chief Medical Officer | 9,593 | $4.32 | $41.4K | $0 | 3 | 2023-07-05 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | SVP, Med Affairs, Safety & PV | 35,740 | $19.00 | $679.1K | -$39.5K | 23 | 2022-02-15 |
Recent Filings · Page 2 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-26 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +12,600 | $0 | EDGAR |
| 2021-01-05 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −706 | -$17.4K | EDGAR |
| 2020-11-16 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −319 | -$12.3K | EDGAR |
| 2020-08-14 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −319 | -$17.0K | EDGAR |
| 2020-05-14 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −319 | -$28.4K | EDGAR |
| 2020-02-14 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −319 | -$30.9K | EDGAR |
| 2020-01-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +4,200 | $0 | EDGAR |
| 2020-01-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | −349 | -$61.7K | EDGAR |
| 2019-12-30 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | — | -$3.8K | EDGAR |
| 2019-12-05 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Exer (M) | +80 | $4.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.